NIAID Expands Nationwide Network of Vaccine and Treatment Evaluation Units

Visit us on the Web Follow us on Twitter Visit us on Facebook Follow us on LinkedIn NIAID Expands Nationwide Network of Vaccine and Treatment Evaluation Units This month, NIAID awarded nine contracts to strengthen and broaden the scope of its Vaccine and Treatment Evaluation Units (VTEUs), a nationwide group of institutions that has conducted clinical trials of candidate vaccines and therapies for more than 50 years.  The new set of awards increases the number of funded institutions from eight to nine and expands the VTEUs’ ability to study infectious diseases in both domestic and international settings. By studying diseases where they are endemic, scientists will be able to learn more about the origin and evolution of emerging diseases and improve the evaluation of candidate diagnostics, vaccines, and treatments. For more on the VTEUs’ past accomplishments and the new contracts, see the NIAID news release at: http://www.niaid.nih.gov/news/newsreleases/2013/Pages/vteu.aspx. Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: National Institute of Allergy and Infectious Diseases · 6610 Rockledge Drive · Bethesda, MD 20892 · 866-284-4107